Company Filing History:
2 out of 1,500 
1 out of 14 
1 out of 6 Years Active: 2010-2015
Title: Innovations of Jonas Malmstrom
Introduction
Jonas Malmstrom is a notable inventor based in Sodertalje, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for therapeutic uses. With a total of four patents to his name, Malmstrom's work focuses on innovative solutions for medical challenges.
Latest Patents
Malmstrom's latest patents include "Heteroaryl substituted benzothiazoles," which relates to novel heteroaryl substituted benzothiazole derivatives and their therapeutic applications. This invention includes methods for imaging amyloid deposits in living patients, which is crucial for the antemortem diagnosis of Alzheimer's disease. Another significant patent is for "2-carboxamide-7-piperazinyl-benzofuran derivatives," which involves new intermediates useful in the preparation of these compounds.
Career Highlights
Throughout his career, Malmstrom has worked with prominent companies such as AstraZeneca AB and Navidea Biopharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and research.
Collaborations
Malmstrom has collaborated with notable colleagues, including Gunnar Nordvall and David Pyring. These partnerships have likely enhanced his research and development efforts in the pharmaceutical field.
Conclusion
Jonas Malmstrom's contributions to pharmaceutical innovations through his patents and collaborations highlight his role as a significant inventor in the industry. His work continues to impact the diagnosis and treatment of critical medical conditions.